Semaglutide 1.0 mg weekly bests Liraglutide 3.0 mg daily for post bariatric surgery weight recurrence Dr. Mahalakshmi Sivashankaran23 April 2023 8:15 PM ISTUSA: Semaglutide has been shown to be more effective than liraglutide in treating post-metabolic and bariatric surgery (MBS) weight recurrence,...
Novo Nordisk raises full-year forecast on GLP-1 drug sales Ruchika Sharma16 April 2023 10:00 AM ISTThe guidance upgrade also partly reflected higher expected sales in the U.S. of its Ozempic diabetes drug, which is based on the same active...
Novo Nordisk diabetes drug Ozempic back on shelves in US after months of shortage Ruchika Sharma19 March 2023 1:00 PM ISTUS: Novo Nordisk's best-selling diabetes treatment drug Ozempic is back on the shelves in the United States after months of shortage, the U.S....
Switching from liraglutide to semaglutide leads to weight loss and improves blood sugar control in type 2 diabetes Dr Kartikeya Kohli15 March 2023 11:30 AM ISTJapan: Switching from once-daily liraglutide to once-weekly semaglutide 0.5 mg notably improves blood sugar control and body weight versus switching...
Semaglutide advisable option for preservation of beta cell function in diabetes patients Aditi8 Feb 2023 11:15 AM ISTItaly: An original research article published in Frontiers in Endocrinology has mentioned that Semaglutide preserves the functioning of β-cell. It...
Semaglutide helps control food cravings in addition to weight loss in overweight adults Medha Baranwal28 Jan 2023 11:30 AM ISTCanada: Semaglutide 2.4 mg improves short- and longer-term control of eating in adults with obesity/overweight, says a recent study published in...
USFDA approves label update for Rybelsus allowing use as first-line option for adults with type 2 diabetes: Novo Nordisk Ruchika Sharma16 Jan 2023 4:15 PM ISTPlainsboro: Novo Nordisk has announced that the U.S. Food and Drug Administration (FDA) has approved a label update for Rybelsus (semaglutide) tablets...
FDA approves injectable semaglutide for people with obesity ages 12 and more Dr. Kamal Kant Kohli1 Jan 2023 8:00 PM ISTThe U.S. Food and Drug Administration (FDA) has approved a new indication for Wegovy (semaglutide) injection 2.4 mg, making it the first-and-only...
Subcutaneous semaglutide beneficial in weight loss management says JAMA Jacinthlyn Sylvia7 Dec 2022 10:45 AM ISTUSA: Weekly semaglutide dosages of 1.7 mg and 2.4 mg were linked to weight reduction says a study published in the Journal of American Medical...
Semaglutide significantly effective for weight loss in teenagers too: NEJM Study Medha Baranwal4 Nov 2022 11:30 AM ISTAustria: Semaglutide is an obesity drug that mimics a hormone called glucagon-like peptide-1 to target areas of the brain that decrease appetite and...
SC semaglutide, if given continuously for two years, maintains weight loss in obese adults: STEP 5 trial Medha Baranwal20 Oct 2022 8:00 PM ISTUSA: Findings from the STEP 5 trial showed that weekly semaglutide 2.4 mg treatment led to substantial, sustained weight loss for two years in...
Submit safety data of initial 30 subjects : CDSCO Tells Novo-Nordisk On IcoSema and insulin icodec study Dr. Divya Colin28 Sept 2022 6:00 PM ISTNew Delhi: Citing to remove the 'interim analysis' from the said condition, the Subject Expert Committee (SEC) functional under Central Drug Standard...
